	US 12,268,716 B2
	Composition containing microorganisms derived from living body and method for manufacturing the same
Shin Shimizu, Osaka (JP)
Assigned to SHINBIOSIS CORPORATION, Osaka (JP)
Appl. No. 16/617,691
Filed by SHINBIOSIS CORPORATION, Osaka (JP)
PCT Filed Feb. 27, 2019, PCT No. PCT/JP2019/007574 § 371(c)(1), (2) Date Nov. 27, 2019, PCT Pub. No. WO2019/168034, PCT Pub. Date Sep. 6, 2019.
Claims priority of application No. 2018-036062 (JP), filed on Feb. 28, 2018.
Prior Publication US 2020/0171103 A1, Jun. 4, 2020
Int. Cl. A61K 35/741 (2015.01); A61K 9/00 (2006.01); A61K 9/10 (2006.01); A61P 1/00 (2006.01); B82Y 5/00 (2011.01)

CPC A61K 35/741 (2013.01) [A61K 9/0031 (2013.01); A61P 1/00 (2018.01); A61K 9/10 (2013.01); B82Y 5/00 (2013.01)]

9 Claims

1. A composition containing intestinal bacteria isolated from a human subject, the composition comprising:

(I) intestinal flora collected from one or more healthy humans or at least one intestinal bacteria isolated from the intestinal flora, wherein the intestinal flora or the intestinal bacteria is always suspended in nanobubble water or immersed in the nanobubble water after the collection;

and

(II) nanobubble water including gas bubbles, wherein the gas bubbles consist of one or two gas components selected from air, hydrogen, or carbon dioxide and have an average diameter of smaller than 1,000 nm.